1. Executive Summary (Confidence: High)

The Longevity Fund by Clinique La Prairie (CLP) represents a significant institutional step toward bridging the gap between groundbreaking longevity science and practical real-world applications. Launched on April 1, 2025, the fund is structured as a sub-fund of the EFG Alternative Investment SICAV-RAIF in Luxembourg, with a target size of EUR 300 million. Led by Co-Chairs Simone Gibertoni and Professor Stefan Catsicas, and joined by Partner Max Gottschalk, the fund aims to become a global leader in longevity investment by backing pioneering companies with "scientific depth and measurable impact". Its investment strategy is deeply rooted in Clinique La Prairie’s clinical philosophy, focusing on the convergence of medical technology, AI-driven personalization, and regenerative therapies.